The Powerhouse Bacterium: Akkermansia muciniphila – Your Gut’s Ally?

The human gut is a complex ecosystem teeming with microorganisms that play critical roles in maintaining our health. One particularly interesting bacterium in the gut microbiome is Akkermansia muciniphila, which has garnered significant attention for its potential health benefits since its discovery in 2004 (1,2).

Meet A. muciniphila: The Mucus-Loving Marvel

A. muciniphila is a unique bacterium that thrives in the mucus lining of the gut. Discovered by researchers Muriel Derrien and Willem de Vos at Wageningen University in the Netherlands, this bacterium is distinguished by its ability to break down mucin, a glycoprotein that forms a protective mucus layer in the gut (1). This mucus layer is essential for gut health, serving as a barrier and a nutrient source for certain microbes (3-6).

Unveiling A. muciniphila: A Key Player in Gut Health and Nutrient Cycling

One of the most abundant species in the gut microbiota, A. muciniphila‘s prevalence can be influenced by factors such as age, location, genotype, diet, and physiological status (2,7). In a dataset of 73,147 DayTwo users, A. muciniphila was present in 66.8% of individuals, albeit in varying quantities. Residing at the oxic-anoxic interface of the gut, this bacterium plays a vital role in the nutrient-sharing system among gut-associated microbial communities (8).

One of the fascinating things about A. muciniphila is its ability to break down mucin, a protein that forms mucus in the gut. As it degrades mucin, A. muciniphila releases monosaccharides into the environment. Other gut bacteria can then utilize these simple sugars, contributing to a nutrient-sharing system in gut-associated microbial communities (9). Moreover, mucin degradation can produce beneficial products such as short-chain fatty acids. These compounds aid in the growth of other bacteria and maintain healthy mucus turnover, further emphasizing the crucial role of A. muciniphila in maintaining gut health  (10-11).

A. muciniphila and GLP-1: A Gut Hormone Connection

Recent scientific research has unveiled a fascinating connection between Akkermansia muciniphila and the gut hormone GLP-1 (glucagon-like peptide-1), which plays a vital role in regulating appetite and glucose metabolism. Studies have shown that increasing the abundance of A. muciniphila in the gut can lead to elevated levels of GLP-1, contributing to improved glucose tolerance and enhanced insulin sensitivity.

GLP-1 is a hormone released from the gut in response to food intake, promoting insulin secretion and reducing appetite. The presence of A. muciniphila in the gut has been associated with increased GLP-1 production, which can help regulate blood sugar levels and support weight management. This connection suggests that A. muciniphila may be a valuable ally in managing conditions like type 2 diabetes and obesity by influencing hormonal pathways.

Recent research has identified a specific protein, Amuc_1100, produced by A. muciniphila, which can stimulate GLP-1 secretion, enhancing glucose homeostasis. This protein has shown potential in improving metabolic health by boosting GLP-1 levels, thereby improving insulin sensitivity and reducing inflammation (12).

Furthermore, studies have demonstrated that supplementation with A. muciniphila or its proteins can lead to significant improvements in glucose regulation and metabolic health in both animal models and human trials. These findings underscore the potential of A. muciniphila as a next-generation probiotic for metabolic health (13).

A. muciniphila: The Gut Health Guardian and Beyond

Research indicates that A. muciniphila is crucial for gut health and has broader health implications (14). It is implicated in immune system modulation, with studies suggesting its potential role in inflammatory bowel disease and certain cancers (14-16). Moreover, emerging research on the gut-brain axis suggests that A. muciniphila might influence mental health by affecting mood and behavior (17-18).

Interestingly, A. muciniphila has been associated with metabolic health, including leanness and resistance to obesity and type 2 diabetes (19-20). A higher abundance of A. muciniphila correlates with a healthier metabolic status in overweight/obese individuals (21-22). Studies have shown that administering live A. muciniphila can improve insulin resistance and glucose intolerance, positioning it as a promising candidate for anti-obesity therapies (21, 23).

A. muciniphila: A Double-Edged Sword in Pathogen Susceptibility

Recent findings reveal that A. muciniphila‘s impact on pathogen susceptibility can be diet-dependent. Research has shown that in the absence of dietary fiber, A. muciniphila may increase susceptibility to mucosal pathogens. However, with sufficient dietary fiber, it can reduce pathogen load, underscoring the importance of diet in modulating the effects of gut bacteria (24).

These observations suggest that A. muciniphila may enhance pathogen susceptibility through increased mucus penetrability and altered microbial activity, rather than direct immune modulation. These insights highlight the complex interplay between diet, gut microbiota, and host health.

Deciphering the Role of A. muciniphila in Obesity: Insights from DayTwo’s Microbiome Data

Our data indicates that levels of A. muciniphila are significantly lower in individuals with obesity compared to those without. Interestingly, females generally have higher levels of A. muciniphila, regardless of obesity status. The reasons for this gender difference remain unclear and warrant further investigation.

The findings from our data could have important implications for understanding the role of A. muciniphila in health and disease. However, it’s important to note that more research is required to establish causal relationships and unravel the underlying mechanisms. This will be instrumental in developing potential therapeutic strategies. Fortunately, DayTwo has a rich dataset of full-shotgun sequenced gut microbiome samples, backed by continuously updating electronic medical records. Our data doesn’t just include clinically diagnosed obese patients, but it also allows us to delve into their co-occurring diagnoses, lab measures, and medications they are taking. This holistic approach provides us with a unique opportunity to explore the intricate connections between our gut microbiome and our health.

A Closer Look at Your Microbiome: A. muciniphila

In our personalized microbiome reports, we provide insights into the levels of beneficial bacteria like A. muciniphila. 

For instance, the example report shows a score of 6.4 out of 10 for A. muciniphila, indicating a mid-level presence. This suggests that there is potential to further boost the levels of this important bacterium to enhance health benefits.

Boosting A. muciniphila: Dietary Strategies

While research is ongoing, certain dietary strategies may enhance A. muciniphila abundance and promote gut health:

• Feast on Fiber and Polyphenols: A diet rich in fresh fruits, vegetables, and whole grains supports A. muciniphila growth (25).
• Incorporate Prebiotic Fibers: These fibers reach the colon intact and nourish beneficial microbes like A. muciniphila (26).
• Eat Polyphenol-Rich Foods: Polyphenols act as prebiotic sources, benefiting A. muciniphila and other gut bacteria (27).
• Include Healthy Fats: Consuming fish oil, flaxseed, and olives may enhance A. muciniphila populations by promoting gut mucus health (15).

A balanced and diverse diet is key to maintaining a healthy gut microbiome. Consult with a healthcare provider before making significant dietary changes.

Conclusion

At DayTwo, we are excited about the potential of A. muciniphila and other gut bacteria in transforming our understanding of health and disease. By leveraging advanced AI and extensive microbiome data, we aim to provide personalized insights and recommendations. Stay tuned for more updates on microbiome research and its implications for health.

References

1. Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol (2004) 54:1469–76.
2. Iwaza, R., Wasfy, R. M., Dubourg, G., Raoult, D., & Lagier, J. C. (2022). Akkermansia muciniphila: The state of the art, 18 years after its first discovery. Frontiers in Gastroenterology, 1, 1024393.
3. Collado, M. C., Derrien, M., Isolauri, E., de Vos, W. M., and Salminen, S. (2007). Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Environ. Microbiol. 73, 7767–7770. doi: 10.1128/AEM.01477-07
4. Behera, S. K., Praharaj, A. B., Dehury, B., & Negi, S. (2015). Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases. Glycoconjugate journal, 32, 575-613.
5. Sheng, Y. H., & Hasnain, S. Z. (2022). Mucus and mucins: the underappreciated host defence system. Frontiers in Cellular and Infection Microbiology, 12, 856962.
6. Grondin, J. A., Kwon, Y. H., Far, P. M., Haq, S., & Khan, W. I. (2020). Mucins in intestinal mucosal defense and inflammation: learning from clinical and experimental studies. Frontiers in immunology, 11, 2054.
7. Cani, P. D., & de Vos, W. M. (2017). Next-generation beneficial microbes: the case of Akkermansia muciniphila. Frontiers in microbiology, 8, 1765.
8. Ouwerkerk, J. P., van der Ark, K. C., Davids, M., Claassens, N. J., Finestra, T. R., de Vos, W. M., & Belzer, C. (2016). Adaptation of Akkermansia muciniphila to the oxic-anoxic interface of the mucus layer. Applied and environmental microbiology, 82(23), 6983-6993.
9. Elzinga, J., Narimatsu, Y., de Haan, N., Clausen, H., de Vos, W. M., & Tytgat, H. L. (2024). Binding of Akkermansia muciniphila to mucin is O-glycan specific. Nature Communications, 15(1), 4582.
10. Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., De Barba, C., Barberio, B., … & Savarino, E. V. (2024). Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications. Life, 14(5), 559.
11. Li, Y., Huang, Y., Liang, H., Wang, W., Li, B., Liu, T., … & Huang, T. (2023). The roles and applications of short-chain fatty acids derived from microbial fermentation of dietary fibers in human cancer. Frontiers in Nutrition, 10, 1243390.
12. Di, W., Zhang, Y., Zhang, X., Han, L., Zhao, L., Hao, Y., & Zhai, Z. (2024). Heterologous expression of P9 from Akkermansia muciniphila increases the GLP-1 secretion of intestinal L cells. World Journal of Microbiology and Biotechnology, 40(7), 1-8.
13. Segers, A., & de Vos, W. M. (2023). Mode of action of Akkermansia muciniphila in the intestinal dialogue: role of extracellular proteins, metabolites and cell envelope components. Microbiome research reports, 2(1).
14. Rodrigues, V. F., Elias-Oliveira, J., Pereira, Í. S., Pereira, J. A., Barbosa, S. C., Machado, M. S. G., & Carlos, D. (2022). Akkermansia muciniphila and gut immune system: a good friendship that attenuates inflammatory bowel disease, obesity, and diabetes. Frontiers in immunology, 13, 934695.
15. Mruk-Mazurkiewicz, H., Kulaszyńska, M., Czarnecka, W., Podkówka, A., Ekstedt, N., Zawodny, P., … & Skonieczna-Żydecka, K. (2024). Insights into the Mechanisms of Action of Akkermansia muciniphila in the Treatment of Non-Communicable Diseases. Nutrients, 16(11), 1695.
16. Wang, L., & Tang, D. (2024). Akkermania muciniphila: a rising star in tumor immunology. Clinical and Translational Oncology, 1-13.
17. Lei, W., Cheng, Y., Gao, J., Liu, X., Shao, L., Kong, Q., … & Hu, W. (2023). Akkermansia muciniphila in neuropsychiatric disorders: friend or foe?. Frontiers in cellular and infection microbiology, 13, 1224155.
18. Guo, H., Liu, X., Chen, T., Wang, X., & Zhang, X. (2024). Akkermansia muciniphila improves depressive-like symptoms by modulating the level of 5-HT neurotransmitters in the gut and brain of mice. Molecular Neurobiology, 61(2), 821-834.
19. Xu, Y., Wang, N., Tan, H. Y., Li, S., Zhang, C., & Feng, Y. (2020). Function of Akkermansia muciniphila in obesity: interactions with lipid metabolism, immune response and gut systems. Frontiers in microbiology, 11, 219.
20. Dao, M. C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E. O., … & MICRO-Obes Consortium. (2016). Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut, 65(3), 426-436.
21. Niu, H., Zhou, M., Zogona, D., Xing, Z., Wu, T., Chen, R., … & Xu, X. (2024). Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases. Frontiers in Immunology, 15, 1370658.
22. Abuqwider, J. N., Mauriello, G., & Altamimi, M. (2021). Akkermansia muciniphila, a new generation of beneficial microbiota in modulating obesity: a systematic review. Microorganisms, 9(5), 1098.
23. Zhou, Q., Zhang, Y., Wang, X., Yang, R., Zhu, X., Zhang, Y., … & Sun, L. (2020). Gut bacteria Akkermansia is associated with reduced risk of obesity: evidence from the American Gut Project. Nutrition & metabolism, 17, 1-9.
24. Wolter, M., Grant, E. T., Boudaud, M., Pudlo, N. A., Pereira, G. V., Eaton, K. A., … & Desai, M. S. (2024). Diet-driven differential response of Akkermansia muciniphila modulates pathogen susceptibility. Molecular Systems Biology, 20(6), 596-625.
25. Abbasi, A., Bazzaz, S., Da Cruz, A. G., Khorshidian, N., Saadat, Y. R., Sabahi, S., … & Mortazavian, A. M. (2023). A Critical Review on Akkermansia Muciniphila: Functional Mechanisms, Technological Challenges, and Safety Issues. Probiotics and Antimicrobial Proteins, 1-23.
26. Zhou, K. (2017). Strategies to promote abundance of Akkermansia muciniphila, an emerging probiotics in the gut, evidence from dietary intervention studies. Journal of functional foods, 33, 194-201.
27. Yue, C., Chu, C., Zhao, J., Zhang, H., Chen, W., & Zhai, Q. (2022). Dietary strategies to promote the abundance of intestinal Akkermansia muciniphila, a focus on the effect of plant extracts. Journal of Functional Foods, 93, 105093.